Return to homepagePandemic Pact

COVID-19 infection in HIV-infected patients included in CoRIS

  • Funded by National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
  • Total publications:0 publications

Grant number: COV20_00108

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)

  • Principal Investigator

    Juan Berenguer

  • Research Location

    Spain

  • Lead Research Institution

    FUNDACION INVESTIGACION BIOMEDICA HOSPITAL GREGORIO MARAÑON

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

To date, only anecdotal cases of COVID-19 have been described in HIV-infected people. This supports the hypothesis that antiretroviral drugs might have some protective effect against SARS-CoV-2 infection. In order to have reliable information about the incidence of symptomatic or asymptomatic SARS-CoV-2 infection, we intend to carry out a retrospective study within the scope of the Cohort of the Spanish AIDS Research Network (CoRIS). Objectives: (i) describe the frequency and epidemiological and clinical characteristics of patients with COVID-19 in CoRIS, as well as the prognostic factors for the requirement of intensive care, use of mechanical ventilation, length of stay and mortality; and (ii) Study the prevalence of antibodies against SARS-CoV-2 by determining IgG and IgM antibodies by ELISA